Interestingly, despite that PPA1-DOX and PPA1 are expected to harbour similar targeting ability in principle, the PPA1-DOX treatment led to effective suppression of tumor growth and longer survival time superior to free PPA1 treatment, most probably benefited from the cytotoxic effect of DOX once released into tumor tissues (Figures 5B, C). Here, PPA1 is linked to neoplasm.